Comprehensive immunogenicity data of individualized neoantigen therapeutic vaccine (INTV) TG4050, from the randomized Phase I study in operable ...
Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk chronic lymphocytic leukemia (CLL), ...
MUD HCT is associated with better survival outcomes and fewer severe complications compared to haploidentical HCT in acute ...
We got to know Ellie's struggle with sobriety better when Matlock Season 2 Episode 4's case triggered Matty's memories. Our ...
RIVERSIDE, Calif. – Resurgence Behavioral Health in Riverside announced the release of its latest educational article, “How Can You Use the Five Rules of Recovery to Stay Sober?”, offering practical ...
Brexucabtagene autoleucel shows promising efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia, including patients with CNS involvement. Brexucabtagene autoleucel (brexu-cel; ...
The risk for central nervous system (CNS) involvement is small in cases of diffuse large B-cell lymphoma (DLBCL) because only about 5% of patients develop it. But certain high-risk patients are even ...